1,717
Views
44
CrossRef citations to date
0
Altmetric
Review

Extrinsic aging

UV-mediated skin carcinogenesis

, , , &
Pages 285-297 | Received 12 Aug 2012, Accepted 11 Oct 2012, Published online: 01 Jul 2012

References

  • Zouboulis CC, Makrantonaki E. Clinical aspects and molecular diagnostics of skin aging. Clin Dermatol 2011; 29:3 - 14; http://dx.doi.org/10.1016/j.clindermatol.2010.07.001; PMID: 21146726
  • Suppa M, Elliott F, Mikeljevic JS, Mukasa Y, Chan M, Leake S, et al. The determinants of periorbital skin ageing in participants of a melanoma case-control study in the U.K. Br J Dermatol 2011; 165:1011 - 21; http://dx.doi.org/10.1111/j.1365-2133.2011.10536.x; PMID: 21787368
  • Manestar-Blazić T, Batinac T, Hadzisejdić I, Brajac I. Apoptosis and immune response are responsible for the site-specific incidence of non-melanoma skin cancer. Med Hypotheses 2007; 68:853 - 5; http://dx.doi.org/10.1016/j.mehy.2006.08.039; PMID: 17052858
  • Goldberg LH, Mamelak AJ. Review ofactinic keratosis. Part I: etiology, epidemiology and clinical presentation. J Drugs Dermatol 2010; 9:1125 - 32; PMID: 20865846
  • Schmitt JV, Miot HA. Actinic keratosis: a clinical and epidemiological revision. An Bras Dermatol 2012; 87:425 - 34; http://dx.doi.org/10.1590/S0365-05962012000300012; PMID: 22714759
  • Trakatelli M, Charalampidis S, Novakovic LB, Patsatsi A, Kalabalikis D, Sotiriadis D. Photodermatoses with onset in the elderly. Br J Dermatol 2009; 161:Suppl 3 69 - 77; http://dx.doi.org/10.1111/j.1365-2133.2009.09452.x; PMID: 19775360
  • Rass K, Reichrath J. UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer. Adv Exp Med Biol 2008; 624:162 - 78; http://dx.doi.org/10.1007/978-0-387-77574-6_13; PMID: 18348455
  • Hu B, Castillo E, Harewood L, Ostano P, Reymond A, Dummer R, et al. Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signaling. Cell 2012; 149:1207 - 20; http://dx.doi.org/10.1016/j.cell.2012.03.048; PMID: 22682244
  • Duncan KO, Geisse JK, Leffell DJ. Epithelial precancerous lesions. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, ed. Fitzpatrick's Dermatology in General Medicine. 8th ed. Columbus: McGraw-Hill, 2012: 1261-1283.
  • Szeimies RM, Torezan L, Niwa A, Valente N, Unger P, Kohl E, et al. Clinical, histopathological and immunohistochemical assessment of human skin field cancerization before and after photodynamic therapy. Br J Dermatol 2012; 167:150 - 9; http://dx.doi.org/10.1111/j.1365-2133.2012.10887.x; PMID: 22329784
  • Braathen LR, Morton CA, Basset-Seguin N, Bissonnette R, Gerritsen MJ, Gilaberte Y, et al, International Society for Photodynamic Therapy in Dermatology. Photodynamic therapy for skin field cancerization: an international consensus. J Eur Acad Dermatol Venereol 2012; 26:1063 - 6; http://dx.doi.org/10.1111/j.1468-3083.2011.04432.x; PMID: 22220503
  • Zwald FO, Brown M. Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 2011; 65:253 - 61, quiz 262; PMID: 21763561
  • Patel KB. Bowen’s Disease Treated with Imiquimod and Cryotherapy. Indian J Dermatol 2012; 57:239 - 41; http://dx.doi.org/10.4103/0019-5154.96217; PMID: 22707785
  • Kossard S, Rosen R. Cutaneous Bowen’s disease. An analysis of 1001 cases according to age, sex, and site. J Am Acad Dermatol 1992; 27:406 - 10; http://dx.doi.org/10.1016/0190-9622(92)70208-W; PMID: 1401276
  • Rossi R, Calzavara-Pinton PG, Giannetti A, Peserico A, Santucci M, Vena GA, et al. Italian guidelines and therapeutic algorithm for actinic keratoses. G Ital Dermatol Venereol 2009; 144:713 - 23; PMID: 19907409
  • Bangash HK, Colegio OR. Management of non-melanoma skin cancer in immunocompromised solid organ transplant recipients. Curr Treat Options Oncol 2012; 13:354 - 76; http://dx.doi.org/10.1007/s11864-012-0195-3; PMID: 22592596
  • Samarasinghe V, Madan V. Nonmelanoma skin cancer. J Cutan Aesthet Surg 2012; 5:3 - 10; http://dx.doi.org/10.4103/0974-2077.94323; PMID: 22557848
  • Spandau DF, Lewis DA, Somani AK, Travers JB. Fractionated laser resurfacing corrects the inappropriate UVB response in geriatric skin. J Invest Dermatol 2012; 132:1591 - 6; http://dx.doi.org/10.1038/jid.2012.29; PMID: 22377757
  • Kasper M, Jaks V, Hohl D, Toftgård R. Basal cell carcinoma - molecular biology and potential new therapies. J Clin Invest 2012; 122:455 - 63; http://dx.doi.org/10.1172/JCI58779; PMID: 22293184
  • Trakatelli M, Ulrich C, del Marmol V, Euvrard S, Stockfleth E, Abeni D. Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Br J Dermatol 2007; 156:Suppl 3 1 - 7; http://dx.doi.org/10.1111/j.1365-2133.2007.07861.x; PMID: 17488399
  • de Vries E, Micallef R, Brewster DH, Gibbs JH, Flohil SC, Saksela O, et al, EPIDERM Group. Population-based estimates of the occurrence of multiple vs first primary basal cell carcinomas in 4 European regions. Arch Dermatol 2012; 148:347 - 54; http://dx.doi.org/10.1001/archdermatol.2011.2244; PMID: 22431775
  • Chinem VP, Miot HA. Epidemiology of basal cell carcinoma. An Bras Dermatol 2011; 86:292 - 305; http://dx.doi.org/10.1590/S0365-05962011000200013; PMID: 21603813
  • Castori M, Morrone A, Kanitakis J, Grammatico P. Genetic skin diseases predisposing to basal cell carcinoma. Eur J Dermatol 2012; 22:299 - 309; PMID: 22391625
  • Tang JY. Elucidating the role of molecular signaling pathways in the tumorigenesis of basal cell carcinoma. Semin Cutan Med Surg 2011; 30:Suppl S6 - 9; http://dx.doi.org/10.1016/j.sder.2011.11.001; PMID: 22177103
  • Gupta S, Takebe N, Lorusso P. Targeting the Hedgehog pathway in cancer. Ther Adv Med Oncol 2010; 2:237 - 50; http://dx.doi.org/10.1177/1758834010366430; PMID: 21789137
  • Low JA, de Sauvage FJ. Clinical experience with Hedgehog pathway inhibitors. J Clin Oncol 2010; 28:5321 - 6; http://dx.doi.org/10.1200/JCO.2010.27.9943; PMID: 21041712
  • Ritchie SA, Patel MJ, Miller SJ. Therapeutic options to decrease actinic keratosis and squamous cell carcinoma incidence and progression in solid organ transplant recipients: a practical approach. Dermatol Surg 2012; 38:1604 - 21; http://dx.doi.org/10.1111/j.1524-4725.2012.02452.x; PMID: 22646842
  • Berg D, Otley CC. Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47:1 - 17, quiz 18-20; http://dx.doi.org/10.1067/mjd.2002.125579; PMID: 12077575
  • Carucci JA, Leffell DJ, Pettersen JS. Basal cell carcinoma. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, ed. Fitzpatrick's Dermatology in General Medicine. 8th ed. Columbus: McGraw-Hill, 2012: 1294-1303.
  • Puig S, Cecilia N, Malvehy J. Dermoscopic criteria and basal cell carcinoma. G Ital Dermatol Venereol 2012; 147:135 - 40; PMID: 22481576
  • Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R. Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion. J Am Acad Dermatol 2005; 53:458 - 63; http://dx.doi.org/10.1016/j.jaad.2005.04.089; PMID: 16112353
  • Hakverdi S, Balci DD, Dogramaci CA, Toprak S, Yaldiz M. Retrospective analysis of basal cell carcinoma. Indian J Dermatol Venereol Leprol 2011; 77:251; http://dx.doi.org/10.4103/0378-6323.77483; PMID: 21393972
  • Gropper AB, Girouard SD, Hojman LP, Huang SJ, Qian X, Murphy GF, et al. Metastatic basal cell carcinoma of the posterior neck: case report and review of the literature. J Cutan Pathol 2012; 39:526 - 34; http://dx.doi.org/10.1111/j.1600-0560.2012.01871.x; PMID: 22515224
  • Weinstock MA, Still JM. Assessing current treatment options for patients with severe/advanced basal cell carcinoma. Semin Cutan Med Surg 2011; 30:Suppl S10 - 3; http://dx.doi.org/10.1016/j.sder.2011.11.004; PMID: 22177101
  • Martorell-Calatayud A, Sanmartín Jimenez O, Cruz Mojarrieta J, Guillén Barona C. Cutaneous Squamous Cell Carcinoma: Defining the High-Risk Variant. Actas Dermosifiliogr 2012; In Press PMID: 22770898
  • Grossman D, Leffell DJ. Squamous cell carcinoma. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, ed. Fitzpatrick's Dermatology in General Medicine. 8th ed. Columbus: McGraw-Hill, 2012: 1283-94.
  • Lee LA, Huang CG, Liao CT, Lee LY, Hsueh C, Chen TC, et al. Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival. PLoS One 2012; 7:e40767; http://dx.doi.org/10.1371/journal.pone.0040767; PMID: 22808258
  • Marques-Silva L, Farias LC, Fraga CA, de Oliveira MV, Cardos CM, Fonseca-Silva T, et al. HPV-16/18 detection does not affect the prognosis of head and neck squamous cell carcinoma in younger and older patients. Oncol Lett 2012; 3:945 - 9; PMID: 22741024
  • Arron ST, Jennings L, Nindl I, Rosl F, Bouwes Bavinck JN, Seçkin D, et al, Viral Working Group of the International Transplant Skin Cancer Collaborative (ITSCC) & Skin Care in Organ Transplant Patients, Europe (SCOPE). Viral oncogenesis and its role in nonmelanoma skin cancer. Br J Dermatol 2011; 164:1201 - 13; http://dx.doi.org/10.1111/j.1365-2133.2011.10322.x; PMID: 21418174
  • Andersson K, Michael KM, Luostarinen T, Waterboer T, Gislefoss R, Hakulinen T, et al. Prospective study of human papillomavirus seropositivity and risk of nonmelanoma skin cancer. Am J Epidemiol 2012; 175:685 - 95; http://dx.doi.org/10.1093/aje/kwr373; PMID: 22419740
  • Allam E, Zhang W, Al-Shibani N, Sun J, Labban N, Song F, et al. Effects of cigarette smoke condensate on oral squamous cell carcinoma cells. Arch Oral Biol 2011; 56:1154 - 61; http://dx.doi.org/10.1016/j.archoralbio.2011.03.008; PMID: 21489402
  • Spandau DF, Lewis DA, Somani AK, Travers JB. Fractionated laser resurfacing corrects the inappropriate UVB response in geriatric skin. J Invest Dermatol 2012; 132:1591 - 6; http://dx.doi.org/10.1038/jid.2012.29; PMID: 22377757
  • El-Hawary AK, Yassin E, Khater A, Abdelgaber S. Expression of Matrix Metalloproteinase-13 and Ki-67 in Nonmelanoma Skin Cancer in Xeroderma Pigmentosum and Non-xeroderma Pigmentosum. Am J Dermatopathol 2012; In Press PMID: 22722466
  • Lonsdorf AS, Becker MR, Stockfleth E, Schäkel K, Ulrich C. [Primary and secondary prevention of skin cancer in organ transplant recipients]. Hautarzt 2010; 61:195 - 206; http://dx.doi.org/10.1007/s00105-009-1858-2; PMID: 20177652
  • Ritchie SA, Patel MJ, Miller SJ. Therapeutic options to decrease actinic keratosis and squamous cell carcinoma incidence and progression in solid organ transplant recipients: a practical approach. Dermatol Surg 2012; 38:1604 - 21; http://dx.doi.org/10.1111/j.1524-4725.2012.02452.x; PMID: 22646842
  • Bangash HK, Colegio OR. Management of non-melanoma skin cancer in immunocompromised solid organ transplant recipients. Curr Treat Options Oncol 2012; 13:354 - 76; http://dx.doi.org/10.1007/s11864-012-0195-3; PMID: 22592596
  • Signorell J, Hunziker T, Martinelli M, Koestner SC, Mohacsi PJ. Recurrent non-melanoma skin cancer: remission of field cancerization after conversion from calcineurin inhibitor- to proliferation signal inhibitor-based immunosuppression in a cardiac transplant recipient. Transplant Proc 2010; 42:3871 - 5; http://dx.doi.org/10.1016/j.transproceed.2010.07.090; PMID: 21094874
  • Brash DE, Ziegler A, Jonason AS, Simon JA, Kunala S, Leffell DJ. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Investig Dermatol Symp Proc 1996; 1:136 - 42; PMID: 9627707
  • Ziegler A, Jonason A, Simon J, Leffell D, Brash DE. Tumor suppressor gene mutations and photocarcinogenesis. Photochem Photobiol 1996; 63:432 - 5; http://dx.doi.org/10.1111/j.1751-1097.1996.tb03064.x; PMID: 8934758
  • Johnson TM, Rowe DE, Nelson BR, Swanson NA. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol 1992; 26:467 - 84; http://dx.doi.org/10.1016/0190-9622(92)70074-P; PMID: 1564155
  • Alam M, Ratner DN. Cutaneous squamous-cell carcinoma. N Engl J Med 2001; 344:975 - 83; http://dx.doi.org/10.1056/NEJM200103293441306; PMID: 11274625
  • Chollet A, Hohl D, Perrier P. [Risk of cutaneous squamous cell carcinomas: the role of clinical and pathological reports]. Rev Med Suisse 2012; 8:743 - 6; PMID: 22545495
  • Nuño-González A, Vicente-Martín FJ, Pinedo-Moraleda F, López-Estebaranz JL. High-risk cutaneous squamous cell carcinoma. Actas Dermosifiliogr 2012; 103:567 - 78; http://dx.doi.org/10.1016/j.adengl.2012.08.004; PMID: 22261673
  • Peat B, Insull P, Ayers R. Risk stratification for metastasis from cutaneous squamous cell carcinoma of the head and neck. ANZ J Surg 2012; 82:230 - 3; http://dx.doi.org/10.1111/j.1445-2197.2011.05994.x; PMID: 22510179
  • Brougham ND, Dennett ER, Cameron R, Tan ST. The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors. J Surg Oncol 2012; In Press http://dx.doi.org/10.1002/jso.23155; PMID: 22592943
  • Situm M, Bulat V, Buljan M, Puljiz Z, Situm V, Bolanca Z. Senile lentigo--cosmetic or medical issue of the elderly population. Coll Antropol 2010; 34:Suppl 2 85 - 8; PMID: 21302707
  • Peter RU, Gottlöber P, Nadeshina N, Krähn G, Plewig G, Kind P. Radiation lentigo. A distinct cutaneous lesion after accidental radiation exposure. Arch Dermatol 1997; 133:209 - 11; http://dx.doi.org/10.1001/archderm.1997.03890380081012; PMID: 9041835
  • Grichnik JM, Rhodes AR, Sober AJ. Benign neoplasias and hyperplasias of melanocytes. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, ed. Fitzpatrick's Dermatology in General Medicine. 8th ed. Columbus: McGraw-Hill, 2012: 1377-1410.
  • Hölzle E. Pigmented lesions as a sign of photodamage. Br J Dermatol 1992; 127:Suppl 41 48 - 50; http://dx.doi.org/10.1111/j.1365-2133.1992.tb16989.x; PMID: 1390186
  • Pralong P, Bathelier E, Dalle S, Poulalhon N, Debarbieux S, Thomas L. Dermoscopy of lentigo maligna melanoma: report of 125 cases. Br J Dermatol 2012; 167:280 - 7; http://dx.doi.org/10.1111/j.1365-2133.2012.10932.x; PMID: 22404578
  • Kvaskoff M, Siskind V, Green AC. Risk factors for lentigo maligna melanoma compared with superficial spreading melanoma: a case-control study in Australia. Arch Dermatol 2012; 148:164 - 70; http://dx.doi.org/10.1001/archdermatol.2011.291; PMID: 22004881
  • Le Gal FA, Toutous-Trellu L, Kaya G, Salomon D. [Lentigo maligna: a special melanoma]. Rev Med Suisse 2011; 7:765 - 6, 768-71; PMID: 21568099
  • Situm M, Bolanca Z, Buljan M. Lentigo maligna melanoma--the review. Coll Antropol 2010; 34:Suppl 2 299 - 301; PMID: 21305747
  • Naldi L, Altieri A, Imberti GL, Gallus S, Bosetti C, La Vecchia C, Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology. Sun exposure, phenotypic characteristics, and cutaneous malignant melanoma. An analysis according to different clinico-pathological variants and anatomic locations (Italy). Cancer Causes Control 2005; 16:893 - 9; http://dx.doi.org/10.1007/s10552-005-2300-4; PMID: 16132799
  • Walter SD, King WD, Marrett LD. Association of cutaneous malignant melanoma with intermittent exposure to ultraviolet radiation: results of a case-control study in Ontario, Canada. Int J Epidemiol 1999; 28:418 - 27; http://dx.doi.org/10.1093/ije/28.3.418; PMID: 10405843
  • Feinmesser M, Tsabari C, Fichman S, Hodak E, Sulkes J, Okon E. Differential expression of proliferation- and apoptosis-related markers in lentigo maligna and solar keratosis keratinocytes. Am J Dermatopathol 2003; 25:300 - 7; http://dx.doi.org/10.1097/00000372-200308000-00004; PMID: 12876487
  • Tanaka M, Sawada M, Kobayashi K. Key points in dermoscopic differentiation between lentigo maligna and solar lentigo. J Dermatol 2011; 38:53 - 8; http://dx.doi.org/10.1111/j.1346-8138.2010.01132.x; PMID: 21175756
  • Pralong P, Bathelier E, Dalle S, Poulalhon N, Debarbieux S, Thomas L. Dermoscopy of lentigo maligna melanoma: report of 125 cases. Br J Dermatol 2012; 167:280 - 7; http://dx.doi.org/10.1111/j.1365-2133.2012.10932.x; PMID: 22404578
  • Akay BN, Kocyigit P, Heper AO, Erdem C. Dermatoscopy of flat pigmented facial lesions: diagnostic challenge between pigmented actinic keratosis and lentigo maligna. Br J Dermatol 2010; 163:1212 - 7; http://dx.doi.org/10.1111/j.1365-2133.2010.10025.x; PMID: 21083845
  • Somach SC, Taira JW, Pitha JV, Everett MA. Pigmented lesions in actinically damaged skin. Histopathologic comparison of biopsy and excisional specimens. Arch Dermatol 1996; 132:1297 - 302; http://dx.doi.org/10.1001/archderm.1996.03890350035006; PMID: 8915306
  • Piérard-Franchimont C, Piérard GE. [Melanoma of older subjects]. Rev Med Liege 2011; 66:34 - 40; PMID: 21374959
  • Reed JA, Shea CR. Lentigo maligna: melanoma in situ on chronically sun-damaged skin. Arch Pathol Lab Med 2011; 135:838 - 41; PMID: 21732771
  • Gillen W, Forman SB, Nunley JR, Bhole S, Eliason K, Fox P, et al. Check your skin: insights regarding skin cancer education. J Am Acad Dermatol 2011; 65:427 - 8, 428, e1; http://dx.doi.org/10.1016/j.jaad.2010.11.041; PMID: 21763569
  • Surber C, Pittelkow M, Lautenschlager S. Photoprotection in transplant recipients. Curr Probl Dermatol 2012; 43:171 - 96; http://dx.doi.org/10.1159/000335799; PMID: 22377929
  • Zwald FO, Brown M. Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 2011; 65:263 - 79, quiz 280; PMID: 21763562
  • Tessari G, Girolomoni G. Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management. Dermatol Surg 2012; 38:1622 - 30; http://dx.doi.org/10.1111/j.1524-4725.2012.02520.x; PMID: 22805312
  • National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Basal Cell and Squamous Cell Skin Cancers. 2011;v.1: Available at http://www.nccn.org/professionals/physician_gls/pdf/nmsc.pdf.
  • National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology,Melanoma.Version1.2013.http://www.nccn.org/professionals/physician_gls/pdf/melanoma.pdf
  • Feng L, Wang Z. Clinical trials in chemoprevention of head and neck cancers. Rev Recent Clin Trials 2012; 7:249 - 54; PMID: 22540907
  • Kadakia KC, Barton DL, Loprinzi CL, Sloan JA, Otley CC, Diekmann BB, et al. Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251). Cancer 2012; 118:2128 - 37; http://dx.doi.org/10.1002/cncr.26374; PMID: 21882176
  • Szumiło J, Podlodowska J, Podlodowski W, Starosławska E, Burdan F. [Chemoprevention of oral cancer--clinical and experimental studies]. Pol Merkur Lekarski 2012; 32:138 - 42; PMID: 22590920
  • Wu PA, Stern RS. Topical tretinoin, another failure in the pursuit of practical chemoprevention for non-melanoma skin cancer. J Invest Dermatol 2012; 132:1532 - 5; http://dx.doi.org/10.1038/jid.2012.136; PMID: 22584499
  • Weinstock MA, Bingham SF, Digiovanna JJ, Rizzo AE, Marcolivio K, Hall R, et al, Veterans Affairs Topical Tretinoin Chemoprevention Trial Group. Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial. J Invest Dermatol 2012; 132:1583 - 90; http://dx.doi.org/10.1038/jid.2011.483; PMID: 22318383